ENDRA Financial Statements From 2010 to 2025

NDRA Stock  USD 4.11  0.01  0.24%   
ENDRA Life financial statements provide useful quarterly and yearly information to potential ENDRA Life Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on ENDRA Life financial statements helps investors assess ENDRA Life's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting ENDRA Life's valuation are summarized below:
ENDRA Life Sciences does not right now have any fundamental signals for analysis.
Check ENDRA Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ENDRA Life's main balance sheet or income statement drivers, such as , as well as many indicators such as . ENDRA financial statements analysis is a perfect complement when working with ENDRA Life Valuation or Volatility modules.
  
Check out the analysis of ENDRA Life Correlation against competitors.

ENDRA Life Sciences Company Return On Equity Analysis

ENDRA Life's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current ENDRA Life Return On Equity

    
  -1.49  
Most of ENDRA Life's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ENDRA Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, ENDRA Life Sciences has a Return On Equity of -1.4945. This is 93.77% lower than that of the Health Care Equipment & Supplies sector and 77.63% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.

ENDRA Life Sciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ENDRA Life's current stock value. Our valuation model uses many indicators to compare ENDRA Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ENDRA Life competition to find correlations between indicators driving ENDRA Life's intrinsic value. More Info.
ENDRA Life Sciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ENDRA Life's earnings, one of the primary drivers of an investment's value.

About ENDRA Life Financial Statements

ENDRA Life stakeholders use historical fundamental indicators, such as ENDRA Life's revenue or net income, to determine how well the company is positioned to perform in the future. Although ENDRA Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in ENDRA Life's assets and liabilities are reflected in the revenues and expenses on ENDRA Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ENDRA Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan. Endra Life operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ENDRA Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ENDRA Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Endra Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Endra Life Sciences Stock:
Check out the analysis of ENDRA Life Correlation against competitors.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. If investors know ENDRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ENDRA Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ENDRA Life Sciences is measured differently than its book value, which is the value of ENDRA that is recorded on the company's balance sheet. Investors also form their own opinion of ENDRA Life's value that differs from its market value or its book value, called intrinsic value, which is ENDRA Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ENDRA Life's market value can be influenced by many factors that don't directly affect ENDRA Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ENDRA Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ENDRA Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ENDRA Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.